P3581Real-world effectiveness of stroke prevention in patients with non-valvular atrial fibrillation treated with rivaroxaban vs. phenprocoumon in Germany - insights from the reload study
Bonnemeier, H., Mundhenke, M., Von Mach, T., Huelsebeck, M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
P3600Characteristics of 15mg od rivaroxaban patients from the RELOAD study
Bonnemeier, H., Mundhenke, M., Von Mach, T., Huelsebeck, M.
Published in European heart journal (01.08.2017)
Published in European heart journal (01.08.2017)
Get full text
Journal Article
POSA45 Impact of Nonadherence to DOACs Among Patients with Non-Valvular Atrial Fibrillation in Sweden: Results from a Real-World Cost-Utility Analysis
Blomström Lundqvist, C, Själander, S, Garcia Rodriguez, LA, Åkerborg, Ö, Jin, G, Caleyachetty, A, Huelsebeck, M, Bowrin, K, Schaefer, B, Mahdessian, H, Hofmeister, L, Levin, LÅ
Published in Value in health (01.01.2022)
Published in Value in health (01.01.2022)
Get full text
Journal Article